Mini-Reviews in Medicinal Chemistry
Title:Editorial (Hot Topic: G Protein-Coupled Receptor Biased Agonism: Development Towards Future Selective Therapeutics)
Volume: 12 Issue: 9
Author(s): Stuart Maudsley
Affiliation:
Export Options
About this article
Cite this article as:
Maudsley Stuart, Editorial (Hot Topic: G Protein-Coupled Receptor Biased Agonism: Development Towards Future Selective Therapeutics), Mini-Reviews in Medicinal Chemistry 2012; 12 (9) . https://dx.doi.org/10.2174/138955712800959161
DOI https://dx.doi.org/10.2174/138955712800959161 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
26
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Privileged Pharmacophore of FDA Approved Drugs in Combination with Chalcone Framework: A New Hope for Alzheimer’s Treatment
Combinatorial Chemistry & High Throughput Screening Neurological Disorders in Mice Lacking Glycogenes that are Mainly Expressed in Brain
CNS & Neurological Disorders - Drug Targets Physiological Effect and Therapeutic Application of Alpha Lipoic Acid
Current Medicinal Chemistry Study of the Relationships between COVID-19, Associated Diseases, and Vitamins
Coronaviruses Current Neuropharmacology: Supplement 1
Current Neuropharmacology Lithium - Pharmacological and Toxicological Aspects: The Current State of the Art
Current Medicinal Chemistry Toxicity of Mediterranean Scyphomedusae: An Overview
Central Nervous System Agents in Medicinal Chemistry Interaction Between Genetic Polymorphisms in Renin-Angiotensin System (RAS) and Therapeutic Efficacy of RAS Blockade in IgA Nephropathy
Current Pharmacogenomics Role of Copper in Angiogenesis and Its Medicinal Implications
Current Medicinal Chemistry Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Molecular Evidence of Cryptotanshinone for Treatment and Prevention of Human Cancer
Anti-Cancer Agents in Medicinal Chemistry Post-stroke Constraint-induced Movement Therapy Increases Functional Recovery, Angiogenesis, and Neurogenesis with Enhanced Expression of HIF-1α and VEGF
Current Neurovascular Research Establishment of a Secondary Screening Assay for P/Q-Type Calcium Channel Blockers
Combinatorial Chemistry & High Throughput Screening Recent Patents Pertaining to Immune Modulation and Musculoskeletal Regeneration with Wharton’s Jelly Cells
Recent Patents on Regenerative Medicine Protective Coatings for Porcelain Insulators
Recent Patents on Corrosion Science Tolfenamic Acid Prevents Amyloid β-induced Olfactory Bulb Dysfunction In Vivo
Current Alzheimer Research Targeting Inhibitor of Apoptosis Proteins (IAPs) for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Topical Targeting Therapies for Sexually Transmitted Diseases
Current Nanoscience The Association of MME microRNA Binding Site Polymorphism with the Risk of Late Onset Alzheimer’s Disease in Northern Han Chinese
Current Neurovascular Research Role of PI3K/AKT/mTOR Pathway Associated Oxidative Stress and Cardiac Dysfunction in Takotsubo Syndrome
Current Neurovascular Research